Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01141608 · ClinicalTrials.gov registry record · NA
Exercise as a Treatment for Substance Use Disorders Protocol
A NA study of Stimulant Abuse and Dependence, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 302
- Enrollment target
- 9
- Study locations
NCT01141608: Completed NA study of Stimulant Abuse and Dependence, sponsored by University of Texas Southwestern Medical Center.
NCT01141608 is a NA study of Stimulant Abuse and Dependence that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 302 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01141608, a NA study of Stimulant Abuse and Dependence, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 302 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to investigate if health interventions (intensive exercise or health education) can be used to help improve substance abuse treatment. The primary objective of this protocol is to compare percent days of abstinence between Vigorous Intensity High Dose exercise (VIHD) and Health Education Intervention (HEI) groups based on stimulant (i.e., cocaine, methamphetamine, amphetamine, or other stimulant, excluding caffeine and nicotine) use during a 12-week acute phase.
Primary Outcome
Percent days of abstinence based on stimulant (i.e., cocaine, methamphetamine, amphetamine, or other stimulant, excluding caffeine and nicotine) use during the 12-week acute phase. Days of abstinence will be measured during days 22-84, since it is anticipated that most individuals will be in a highly structured environment during the first 21 days of the study, and therefore would have little opportunity to use substances (i.e., the groups are not likely to differ during this time period). Measu
Conditions Studied
Interventions
- OTHER Vigorous Intensity High Dose Exercise
- OTHER Health Education Intervention
Study Locations (9)
South Carolina
- Charleston VAMC - Charleston
- Morris Village - Columbia
Texas
- Nexus Recovery, Inc. - Dallas
- Memorial Hermann - Houston
Colorado
- Arapahoe House - Denver
Florida
- Gateway Community Services - Jacksonville
Missouri
- Gibson Recovery Center, Inc. - Cape Girardeau
New York
- St. Luke's-Roosevelt - New York
Pennsylvania
- Penn Presbyterian - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01141608 record still lists
NCT01141608 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Stimulant Abuse and Dependence appearing as the primary indexed condition, and to 2 interventions - of which Vigorous Intensity High Dose Exercise is the first listed.
NCT01141608 lists 9 locations in 7 states (South Carolina, Texas, Colorado).
Frequently Asked Questions
What is clinical trial NCT01141608 about?
NCT01141608 is a clinical study titled "Exercise as a Treatment for Substance Use Disorders Protocol". The purpose of this study is to investigate if health interventions (intensive exercise or health education) can be used to help improve substance abuse treatment. The primary objective of this protocol is to compare percent days of abstinence between Vigorous Intensity High Dose exercise (VIHD) and...
What is the current status of trial NCT01141608?
This trial is currently completed. It is a NA study. The enrollment target is 302 participants. The study started on 2010-06. Estimated completion is 2013-02.
What conditions does trial NCT01141608 study?
This clinical trial studies the following conditions: Stimulant Abuse and Dependence.
What interventions are being tested in trial NCT01141608?
The interventions under investigation include: Vigorous Intensity High Dose Exercise (OTHER), Health Education Intervention (OTHER).
Who is sponsoring clinical trial NCT01141608?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01141608 being conducted?
This trial has 9 study locations across Colorado, Florida, Missouri, New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01141608's enrollment target sits among peer trials
302 330th of 2000 higher than 1,671 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia